Peptide mimic of phosphorylcholine, a dominant epitope found on Streptococcus pneumoniae

Infection and Immunity

Volumn 68, Issue 10, 2000, Pages 5778-5784

  Harris, S L ^a   Park, M K ^a   Nahm, M H ^a   Diamond, B ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL POLYSACCHARIDE; BOVINE SERUM ALBUMIN; EPITOPE; PEPTIDE; PEPTIDE 1; PHOSPHORYLCHOLINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL CELL WALL; CONTROLLED STUDY; CROSS RESISTANCE; DRUG DESIGN; FEMALE; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; T LYMPHOCYTE; VACCINE PRODUCTION;

AMINO ACID SEQUENCE; ANIMAL; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL; CATTLE; CROSS REACTIONS; IMMUNIZATION; IMMUNODOMINANT EPITOPES; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA; OPSONINS; PEPTIDES; PHOSPHORYLCHOLINE; PNEUMOCOCCAL INFECTIONS; SERUM ALBUMIN, BOVINE; STREPTOCOCCUS PNEUMONIAE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; VACCINES, CONJUGATE;

EID: 0033806726     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.10.5778-5784.2000     Document Type: Article

References (53)

1. Anti-phosphocholine hybridoma antibodies. II. Functional analysis of binding sites within three antibody families
2. Identification of peptide mimotopes for the fluorescein hapten binding of monoclonal antibody B13-DE1
3. Emergence of drug-resistant pneumococcal infections in the United States
4. Anti-phosphorylcholine antibodies of the T15 idiotype are optimally protective against Streptococcus pneumoniae
5. The effects of subclass on the ability of anti-phosphocholine antibodies to protect mice from fatal infection with Streptococcus pneumoniae
6. Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 Streptococcus pneumoniae
7. Affinity labeling of a phosphorylcholine binding mouse myeloma protein
8. Clonal nature of the immune response to phosphorylcholine. I. Specificity, class, and idiotype of phosphorylcholine-binding receptors on lymphoid cells
9. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds
10. Antigenic properties of peptidic mimics for epitopes of the lipopolysaccharide from Brucella
11. Subclass restriction of murine antibodies. III. Antigens that stimulate IgG3 in mice stimulate IgG2c in rats
12. Rat anti-T15 monoclonal antibodies with specificity for VH- and VH-VL epitopes
13. The use of monozygotic and dizygotic twins to estimate the effects of inheritance on the levels of immunoglobulin isotypes and antibodies to phosphocholine
14. Susceptibility of Streptococcus pneumoniae to penicillin: A prospective microbiological and clinical study
15. Aspects of pneumococcal infection including bacterial virulence, host response and vaccination
16. Serotypes of Streptococcus pneumoniae causing disease
17. Selection of an immunogenic peptide mimic of the capsular polysaccharide of Neisseria meningitidis serogroup A using a peptide display library
18. Sequence changes at the V-D junction of the VH1 heavy chain of anti-phosphocholine antibodies alter binding to and protection against Streptococcus pneumoniae
19. Exploring the basis of peptide-carbohydrate cross-reactivity: Evidence for discrimination by peptides between closely related anti-carbohydrate antibodies
20. The pneumococcal typing system and pneumococcal surveillance
21. Identification of a peptide which binds to the carbohydrate-specific monoclonal antibody B3
22. Human immune response to a peptide mimic of Neisseria meningitidis serogroup C in hu-PBMC-SCID mice
23. Structure of the complex polysaccharide C-substance from Streptococcus pneumoniae type 1
24. Inhibition of self-binding antibodies (autobodies) by a VH-derived peptide
25. Idiotypic self binding of a dominant germline idictype (T15). Autobody activity is affected by antibody valency
26. Antigen binding and idiotype analysis of antibodies obtained after electroporation of heavy and light chain genes encoding phosphocholine-specific antibodies: A model for T15-idiotype dominance
27. Inhibition of phosphorycholine binding to antibodies using synthetic peptides
28. Clonal restriction of the immune response to phosphorylcholine
29. Cross-reactive antibodies have both protective and pathogenic potential
30. Laboratory diagnosis, serology and epidemiology of Streptococcus pneumoniae
31. Monoclonal idiotope vaccine against Streptococcus pneumoniae infection
32. Molecular mimetics of polysaccharide epitopes as vaccine candidates for prevention of Neisseria meningitidis serogroup B disease
33. Inability of mice with a defect in B-lymphocyte maturation to respond to phosphorylcholine on immunogenic carriers
34. An idiotypic determinant formed by both immunoglobulin constant and variable regions
35. Repertoire diversity of antibody response to bacterial antigens in aged mice. III. Phosphorylcholine antibody from young and aged mice differ in structure and protective activity against infection with Streptococcus pneumoniae
36. Epitope location in the Cryptococcus neoformans capsule is a determinant of antibody efficacy
37. Immunoglobulin G3 blocking antibodies to the fungal pathogen Cryptococcus neoformans
38. Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people
39. Induction of anti-carbohydrate antibodies by phage library-selected peptide mimics
40. Peptides that mimic the group B streptococcal type III capsular polysaccharide antigen
41. The 'patchy' immunodeficiency of CBA/N mice
42. Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups
43. Cross-reactions between pneumococci and other streptococci due to C polysaccharide and F antigen
44. T15 PC-binding monoclonal antibodies retain specificity when they switch from IgM to IgG
45. Peptide libraries define the fine specificity of anti-polysaccharide antibodies to Cryptococcus neoformans
46. Aspects of antigen mimicry revealed by immunization with a peptide mimetic of Cryptococcus neoformans polysaccharide
47. Resistance to Streptococcus pneumoniae is induced by a phosphocholine-protein conjugate
48. Peptide mimicry of the meningococcal group C capsular polysaccharide
49. The three-dimensional structures of a polysaccharide binding antibody to Cryptococcus neoformans and its complex with a peptide from a phage display library: Implications for the identification of peptide mimotopes
50. Molecular basis for the lack of mimicry of Brucella polysaccharide antigens by Ab2γ antibodies
51. Isotype switching from IgG3 to IgG1 converts a nonprotective murine antibody to Cryptococcus neoformans into a protective antibody
52. Antibody-mediated modulation of Cryptococcus neoformans infection is dependent on distinct Fc receptor functions and IgG subclasses
53. Isotype switching increases efficacy of antibody protection against Cryptococcus neoformans infection in mice